clobazam
- Product NDC
- 51991-901
- 11-digit product format
- 519910901
- Labeler code
- 51991
- Product ID
- 51991-901_b7fdaf63-fecd-4bcc-bd00-efffe7e9becd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CLOBAZAM
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Application
- ANDA209308
- Marketing category
- ANDA
- Marketing start
- 2018-10-22
- Marketing end
- 0000-00-00
- Substance
- CLOBAZAM
- Active strength
- 20 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51991-901 | CLOBAZAM TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 14 | Legacy NDC | 20230306_dd6a7bde-62c5-43e2-81f8-1f7dd63757b3.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51991-901-01 | 51991090101 | 100 TABLET in 1 BOTTLE (51991-901-01) | 100 tablet | 2018-10-22 | 0000-00-00 | No | No | Current |